第673回千葉医学会整形外科例会 28.

Description of patients included at each time point in each of the development and validation samples. (DOC 37 kb

第702回千葉医学会例会・第1内科教室同門会例会 17.

Description of patients included at each time point in each of the development and validation samples. (DOC 37 kb

Additional file 3: of A cluster randomized controlled trial to assess the impact on intimate partner violence of a 10-session participatory gender training curriculum delivered to women taking part in a group-based microfinance loan scheme in Tanzania (MAISHA CRT01): study protocol

Participant Information and Consent Form for MAISHA CRT01 – Focus Group Discussion. Information provided to potential participants, as part of the informed consent process for focus group discussion, and the informed consent form signed by participants who agree to take part in the focus group discussions. (DOC 51 kb

Additional file 6: Table S4. of National survey and point prevalence study of sedation practice in UK critical care

National survey: first-choice analgesic agent reported by units. (PDF 61 kb

Additional file 4: Table S2. of National survey and point prevalence study of sedation practice in UK critical care

National survey: sedation scale score in use reported by units. (PDF 61 kb

Additional file 17: Table S15. of National survey and point prevalence study of sedation practice in UK critical care

Point prevalence study: characteristics, outcomes and length of stay of sedated and non-sedated patients with validated Case Mix Programme data (n = 50 units). (PDF 86 kb

Additional file 1: Table S1. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units

Site of Candida invasive fungal disease (N = 359). (DOC 31 kb

Additional file 5: Table S4. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units

Final risk models at admission, 24 h and end of calendar day 3. (DOC 44 kb